Commentary
The People’s Republic of China has embarked on a major international distribution push of Sinovac and Sinopharm vaccines worldwide.
A nurse shows a COVID-19 vaccine produced by Chinese company Sinovac Biotech at the Sao Lucas Hospital in Porto Alegre, Brazil, on Aug. 8, 2020. Silvio Avila/AFP via Getty Images
|Updated:
Gabriël Moens
Author
Gabriël A. Moens AM is an emeritus professor of law at the University of Queensland, and served as pro vice-chancellor and dean at Murdoch University. In 2003, Moens was awarded the Australian Centenary Medal by the prime minister for services to education. He has taught extensively across Australia, Asia, Europe, and the United States.
